AdaptHealth Statistics
Total Valuation
AdaptHealth has a market cap or net worth of $1.39 billion. The enterprise value is $3.34 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 133.12 million shares outstanding. The number of shares has decreased by -0.45% in one year.
| Current Share Class | 133.12M |
| Shares Outstanding | 133.12M |
| Shares Change (YoY) | -0.45% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 8.20% |
| Owned by Institutions (%) | 82.23% |
| Float | 85.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.19 |
| PS Ratio | 0.42 |
| Forward PS | 0.38 |
| PB Ratio | 0.92 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.25 |
| P/OCF Ratio | 2.32 |
| PEG Ratio | 0.25 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.74, with an EV/FCF ratio of 17.42.
| EV / Earnings | n/a |
| EV / Sales | 1.02 |
| EV / EBITDA | 5.74 |
| EV / EBIT | 17.89 |
| EV / FCF | 17.42 |
Financial Position
The company has a current ratio of 0.92, with a Debt / Equity ratio of 1.32.
| Current Ratio | 0.92 |
| Quick Ratio | 0.61 |
| Debt / Equity | 1.32 |
| Debt / EBITDA | 3.07 |
| Debt / FCF | 10.42 |
| Interest Coverage | 1.82 |
Financial Efficiency
Return on equity (ROE) is -4.85% and return on invested capital (ROIC) is 5.51%.
| Return on Equity (ROE) | -4.85% |
| Return on Assets (ROA) | 2.64% |
| Return on Invested Capital (ROIC) | 5.51% |
| Return on Capital Employed (ROCE) | 5.08% |
| Weighted Average Cost of Capital (WACC) | 7.67% |
| Revenue Per Employee | $301,539 |
| Profits Per Employee | -$7,305 |
| Employee Count | 10,900 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 18.13 |
Taxes
In the past 12 months, AdaptHealth has paid $44.80 million in taxes.
| Income Tax | 44.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.34% in the last 52 weeks. The beta is 1.57, so AdaptHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | +15.34% |
| 50-Day Moving Average | 11.68 |
| 200-Day Moving Average | 10.14 |
| Relative Strength Index (RSI) | 32.86 |
| Average Volume (20 Days) | 1,540,485 |
Short Selling Information
The latest short interest is 7.97 million, so 5.99% of the outstanding shares have been sold short.
| Short Interest | 7.97M |
| Short Previous Month | 8.01M |
| Short % of Shares Out | 5.99% |
| Short % of Float | 9.29% |
| Short Ratio (days to cover) | 6.30 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.29 billion and -$79.63 million in losses. Loss per share was -$0.59.
| Revenue | 3.29B |
| Gross Profit | 670.35M |
| Operating Income | 186.89M |
| Pretax Income | -30.03M |
| Net Income | -79.63M |
| EBITDA | 582.61M |
| EBIT | 186.89M |
| Loss Per Share | -$0.59 |
Full Income StatementBalance Sheet
The company has $47.96 million in cash and $2.00 billion in debt, with a net cash position of -$1.95 billion or -$14.67 per share.
| Cash & Cash Equivalents | 47.96M |
| Total Debt | 2.00B |
| Net Cash | -1.95B |
| Net Cash Per Share | -$14.67 |
| Equity (Book Value) | 1.51B |
| Book Value Per Share | 11.32 |
| Working Capital | -55.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $599.97 million and capital expenditures -$408.02 million, giving a free cash flow of $191.95 million.
| Operating Cash Flow | 599.97M |
| Capital Expenditures | -408.02M |
| Depreciation & Amortization | 395.72M |
| Net Borrowing | -157.42M |
| Free Cash Flow | 191.95M |
| FCF Per Share | $1.44 |
Full Cash Flow StatementMargins
Gross margin is 20.40%, with operating and profit margins of 5.69% and -2.42%.
| Gross Margin | 20.40% |
| Operating Margin | 5.69% |
| Pretax Margin | -0.91% |
| Profit Margin | -2.42% |
| EBITDA Margin | 17.73% |
| EBIT Margin | 5.69% |
| FCF Margin | 5.84% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.45% |
| Shareholder Yield | 0.45% |
| Earnings Yield | -5.72% |
| FCF Yield | 13.80% |
Analyst Forecast
The average price target for AdaptHealth is $14.00, which is 33.97% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 33.97% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 0.92 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.92 |
| Piotroski F-Score | 5 |
